Similar Articles
1121 Effect and safety of sorafenib in patients with intermediate hepatocellular carcinoma who received transarterial chemoembolization: A retrospective comparative study
1122 Mouse models for investigating the underlying mechanisms of nonalcoholic steatohepatitis-derived hepatocellular carcinoma
1123 Compared efficacy of preservation solutions on the outcome of liver transplantation: Meta-analysis
1124 Analysis of aggressiveness factors in hepatocellular carcinoma patients undergoing transarterial chemoembolization
1125 Impact of enhanced recovery after surgery programs on pancreatic surgery: A meta-analysis
1126 Application of enhanced recovery after gastric cancer surgery: An updated meta-analysis
1127 Hepatocellular carcinoma or interferon-based therapy history attenuates sofosbuvir/ribavirin for Japanese genotype 2 hepatitis C virus
1128 Model combining pre-transplant tumor biomarkers and tumor size shows more utility in predicting hepatocellular carcinoma recurrence and survival than the BALAD models
1129 Role of relevant immune-modulators and cytokines in hepatocellular carcinoma and premalignant hepatic lesions
1130 Proteinase-activated receptor 2 promotes tumor cell proliferation and metastasis by inducing epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA